Course DescriptionThis program will feature a multidisciplinary panel of world-class pathology experts, from both the oncology pathology and medical oncology disciplines, who will highlight optimized diagnosis and recent practice-changing data in the diagnosis and treatment of NSCLC, with a focus on interpreting testing reports and implications for treatment regarding oncogenic gene fusions. This…
Course Director: Olga Pozdnyakova, MD, PhDAvailable Credits 14 CME USCAP Member Practicing Pathologist $999, USCAP Member Pathologists-in-Training $799, Non-Member $1,349 Register Now In the era…
Course Co-Directors: Stuart J. Schnitt, MD and Laura C. Collins, MDAvailable Credits 21.25 CME USCAP Member Practicing Pathologist $999, USCAP Member Pathologists-in-Training $799, Non-Member $1,349…
USCAP’s annual meeting is the largest gathering of pathologists in the world! Catch up on groundbreaking research, learn from pathology legends and much more!
Please follow the link below to access Pathology State of Affairs: Underscoring the Value of Biomarker Testing for Solid Tumors on…
Soak up Mardi Gras season while dive-bar hopping, dancing to brass bands and exploring history in the French Quarter.
USCAP, Palm Springs, California. 14,103 likes · 113 talking about this · 121 were here. Creating a Better Pathologist
USCAP, Palm Springs, California. 14,095 likes · 26 talking about this · 121 were here. Creating a Better Pathologist
Adenoid ameloblastoma is a very rare benign epithelial odontogenic tumor characterized microscopically by epithelium resembling conventional ameloblastoma, with additional duct-like structures, epithelial whorls, and cribriform…
Course Co-Directors: Stuart J. Schnitt, MD and Laura C. Collins, MDAvailable Credits 21.25 CME USCAP Member Price $999, Non-Member Price $1.349, Pathologists-in-Training $799 Register Now…
Course Director: Rhonda K. Yantiss, MDAvailable Credits 24 CMEUSCAP Member Price $1,199, Non-Member Price $1,599, Pathologists-in-Training $899 Register Now IMPORTANT: Please read about USCAP’s COVID-19…
